Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Cash from Investing Activities (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Cash from Investing Activities for 16 consecutive years, with -$4.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Investing Activities rose 29.5% year-over-year to -$4.3 million, compared with a TTM value of -$4.7 million through Sep 2025, down 87.85%, and an annual FY2024 reading of -$4.9 million, down 59.8% over the prior year.
  • Cash from Investing Activities was -$4.3 million for Q3 2025 at Rockwell Medical, down from -$103000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $9.1 million in Q1 2022 and bottomed at -$14.7 million in Q3 2022.
  • Average Cash from Investing Activities over 5 years is -$758368.4, with a median of -$64000.0 recorded in 2023.
  • The sharpest move saw Cash from Investing Activities tumbled 977.42% in 2022, then skyrocketed 2782.81% in 2024.
  • Year by year, Cash from Investing Activities stood at $540000.0 in 2021, then soared by 495.93% to $3.2 million in 2022, then plummeted by 37.6% to $2.0 million in 2023, then tumbled by 116.53% to -$332000.0 in 2024, then tumbled by 1197.89% to -$4.3 million in 2025.
  • Business Quant data shows Cash from Investing Activities for RMTI at -$4.3 million in Q3 2025, -$103000.0 in Q2 2025, and -$1000.0 in Q1 2025.